My #1 Takeover Target for November

"Our Last Biotech Takeover Target Soared 463%...
and I want You to Join Us on This One."

  • Tiny biotech just won the only FDA approved one-time treatment for a solid-tumor cancer
  • Goldman Sachs and 6 other Wall Steet banks have put a "BUY RATING" on the stock... with a 2X price target!
  • Stock trades under $11 a share, but we see a takeover happening north of $30 per share

My #1 Takeover Target for November

"Our Last Biotech Takeover Target Soared 463%... and I want You to Join Us on This One."

  • Tiny biotech just won the only FDA approved one-time treatment for a solid-tumor cancer
  • Goldman Sachs and 6 other Wall Steet banks have put a "BUY RATING" on the stock... with a 2X price target!
  • Stock trades under $11 a share, but we see a takeover happening north of $30 per share